Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics
Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics. Beilstein Journal of Organic Chemistry 2024, 20 (MAY 6 2024), 1029-1036.